Income Statement (TTM)
Biocure Technology Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
|
|---|---|
| Revenue | -0 |
| Change (%) | |
| % of Revenue | 100.00 |
| Cost Of Sales | -0 |
| Change (%) | |
| % of Revenue | 28.26 |
| Gross Operating Profit | -0 |
| Change (%) | |
| % of Revenue | 71.74 |
| SG&A | 2 |
| Change (%) | |
| % of Revenue | -54,571.54 |
| R&D | 1 |
| Change (%) | |
| % of Revenue | -40,585.66 |
| OpEx | 3 |
| Change (%) | |
| % of Revenue | -94,495.29 |
| Operating Income | -3 |
| Change (%) | |
| % of Revenue | 94,595.29 |
| Interest Expense | -0 |
| Change (%) | |
| % of Revenue | 5,455.11 |
| Net Income | -3 |
| Change (%) | |
| % of Revenue | 99,711.02 |
Source: Capital IQ
